Piramal Pharma Solutions (PPS), the global contract manufacturing ... the chairperson had said last week. Piramal’s CDMO ...
Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...
The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...
(NASDAQ:THAR) ("Tharimmune"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, and Intract Pharma Ltd. ("Intract"), a ...
INDIAN pharmaceutical firm Aurobindo Pharma Ltd. plans to establish a facility in the Philippines to manufacture generic ...